Treatment of Noninfectious Retinal Vasculitis Using Subcutaneous Repository Corticotropin Injection
Stephen D. Anesi, Peter Y. Chang, Arash Maleki +8 more2021Journal of Ophthalmic and Vision ResearchJournal Article
CardiovascularHypothalamic-PituitaryOcular
Abstract
Repository corticotropin injection was well-tolerated overall. Repository corticotropin injection may be an effective therapeutic agent in the treatment of noninfectious retinal vasculitis.
References (2)
Related Papers
- Recognition of Melanocytes in Immuno-Neuroendocrinology and Circadian Rhythms: Beyond the Conventional Melanin SynthesisCells · 2022 · 3 shared tags
- Biomarkers Over Time: From Visual Contrast Sensitivity to Transcriptomics in Differentiating Chronic Inflammatory Response Syndrome and Myalgic Encephalomyelitis/Chronic Fatigue SyndromePreprints.org · 2025 · 3 shared tags
- Stimulating the Melanocortin System in Uveitis and Diabetes Preserves the Structure and Anti-Inflammatory Activity of the RetinaInternational Journal of Molecular Sciences · 2023 · 3 shared tags
- Synergistic interaction in simultaneous exposure to Streptomyces californicus and Stachybotrys chartarumEnvironmental Health Perspectives · 2004 · 3 shared tags
- Comparison of inflammatory and cytotoxic lung responses in mice after intratracheal exposure to spores of two different Stachybotrys chartarum strainsToxicological Sciences · 2004 · 3 shared tags
- Localization of Satratoxin-G in Stachybotrys chartarum Spores and Spore-Impacted Mouse Lung Using Immunocytochemistry